Study guide

HLA-B27, sarcoidosis, Behçet disease and VKH

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

HLA-B27, sarcoidosis, Behçet disease and VKH

Key Takeaways Explain This Topic AI

HLA-B27-associated attacks, granulomatous sarcoid patterns and posterior vascular disease have different systemic implications.

Behçet retinal vasculitis can threaten vision even when a single acuity measurement looks relatively good.

VKH assessment includes choroidal activity and systemic findings, with early coordinated control and monitoring of recurrence.

Last updated: October 2026

HLA-B27-Associated Anterior Uveitis

Human Leukocyte Antigen B27 (HLA-B27) is a major histocompatibility complex (MHC) class I surface glycoprotein encoded on chromosome 6. Approximately 50% of all acute non-granulomatous anterior uveitis presentations are HLA-B27 positive, making it the single most common endogenous uveitic syndrome in populations of European descent.

Clinical Phenotype and Presentation

Epidemiology: Typically presents in young adults (second to fourth decades), with a slight male preponderance among individuals with axial spondyloarthritis.

Ocular Hallmarks:

Acute, explosive onset: Rapid development of severe periocular pain, intense ciliary injection, marked photophobia, lacrimation, and blurred vision.

Unilateral and alternating: The inflammation affects usually one eye at a time , but frequently alternates to the contralateral eye during future recurrences. Simultaneous, bilateral acute onset is exceedingly rare ( < 2 % <2\% < 2% ) and should prompt immediate consideration of an alternative etiology (e.g., tubulointerstitial nephritis and uveitis [TINU] syndrome, sarcoidosis, or syphilis).

Heavy Fibrinous Exudate: Pronounced breakdown of the blood-aqueous barrier generates a dense, proteinaceous exudate within the anterior chamber, forming a thick fibrin coagulum across the pupil ( plastic aqueous ).

Hypopyon Formation: Present in 15% to 20% of severe attacks. Unlike the mobile hypopyon of Behçet disease, the HLA-B27 hypopyon is dense, sticky, gelatinous, and relatively fixed due to its high fibrin content.

Posterior Synechiae: High propensity for rapid formation of extensive 360-degree posterior synechiae, predisposing to iris bombé and acute pupillary block glaucoma.

Intraocular Pressure (IOP) Dynamics: IOP is characteristically subnormal initially due to severe ciliary body hyposecretion ("ciliary shock"). As inflammation resolves or if heavy fibrin clogs the trabecular meshwork, IOP may dramatically spike.

Systemic Spondyloarthropathies (SpA)

Approximately 50% of patients with HLA-B27 anterior uveitis have an underlying seronegative spondyloarthropathy:

Ankylosing Spondylitis (AS): The strongest association. Hallmarked by inflammatory back pain (worse at rest and early morning, improves with exercise, nocturnal waking), peripheral enthesitis (Achilles tendonitis, plantar fasciitis), progressive spinal rigidity, and bilateral sacroiliitis visible on pelvic radiography (New York criteria) or early bone marrow oedema on sacroiliac MRI.

Reactive Arthritis: Classically characterized by the clinical triad of urethritis/cervicitis, conjunctivitis/uveitis, and asymmetric oligoarthritis (predominantly involving weight-bearing joints of the lower extremities). Triggered by mucosal gastrointestinal ( Salmonella , Shigella , Campylobacter , Yersinia ) or genitourinary ( Chlamydia trachomatis ) infections. Mucocutaneous signs include circinate balanitis, keratoderma blennorrhagica, and painless oral aphthae.

Psoriatic Arthritis: Associated with cutaneous plaque psoriasis, nail dystrophies (pitting, oil-drop discoloration, onycholysis), and dactylitis ("sausage digits"). Uveitis may be insidious, bilateral, and chronic.

Inflammatory Bowel Disease (IBD): Associated with Crohn disease and Ulcerative Colitis. The activity of anterior uveitis frequently parallels peripheral articular arthritis flares rather than active gastrointestinal colitis flares.

Ocular Sarcoidosis

Sarcoidosis is a multisystem, idiopathic inflammatory disorder characterized pathologically by the formation of non-caseating epithelioid cell granulomas . Ocular involvement occurs in 25% to 50% of patients with systemic sarcoidosis and can affect every structure of the eye and ocular adnexa.

International Workshop on Ocular Sarcoidosis (IWOS) Diagnostic Criteria

The 2019 revised IWOS criteria use three categories after excluding other granulomatous causes:

Definite : Biopsy-supported sarcoidosis with compatible uveitis.

Presumed : No biopsy support, but bilateral hilar lymphadenopathy and at least two specified ocular signs.

Probable : No bilateral hilar lymphadenopathy or biopsy support, with at least three specified ocular signs and two qualifying systemic investigations.

The former possible category is not retained in the revised criteria.

Ocular Signs of Sarcoidosis (IWOS Consensus Signs)

Anterior Segment:

Large, greasy, waxy "mutton-fat" keratic precipitates and/or iris nodules (Koeppe nodules at pupillary border, Busacca nodules on iris stroma).

Trabecular meshwork nodules and/or tent-shaped peripheral anterior synechiae (PAS).

Intermediate and Posterior Segments:

Vitreous opacities presenting as inferior "snowballs" (cellular clumps) or linear aggregations resembling a "string of pearls".

Snowbanking over the inferior pars plana.

Multiple, discrete, punched-out peripheral chorioretinal lesions.

Retinal Periphlebitis: Segmental perivascular sheathing with nodular, yellowish-white exudates resembling candle-wax drippings ( "en taches de bougie" ).

Optic disc granuloma or solitary/multiple choroidal granulomas (yellow-white, subretinal, hypofluorescent on early and late indocyanine green angiography [ICGA]).

Bilateral ocular involvement (present in > 80 % >80\% > 80% of cases).

Diagnostic Investigations in Ocular Sarcoidosis

High-Resolution Chest CT (HRCT): Superior sensitivity to plain radiography for detecting symmetrical bilateral hilar lymphadenopathy (BHL) and subpleural micronodules.

Serum ACE & Lysozyme: Both enzymes are secreted by activated epithelioid macrophages within granulomas; elevated in 60% to 80% of active cases. ACE activity is falsely suppressed by ACE-inhibitor anti-hypertensives.

Tuberculin Skin Test (TST) / IGRA: Demonstrates cutaneous anergy (negative TST in > 80 % >80\% > 80% of sarcoidosis patients despite high population exposure) with a negative IGRA.

Bronchoalveolar Lavage (BAL): Elevated CD4 + : CD8 + \text{CD4}^+:\text{CD8}^+ CD4 + : CD8 + T-cell ratio > 3.5 >3.5 > 3.5 strongly supports pulmonary sarcoidosis.

Behçet Disease

Behçet disease is a systemic, recurrent, obliterative occlusive vasculitis affecting blood vessels of all sizes (arteries and veins) with a high prevalence along the ancient "Silk Road" (Eastern Mediterranean, Middle East, Central Asia, and Japan). It is strongly genetically linked to the HLA-B51 allele (MHC Class I).

Diagnostic Criteria (International Study Group [ISG] & ICBD)

The historical 1990 International Study Group (ISG) classification requires:

Mandatory Criterion: Recurrent oral aphthous ulcerations (observed by physician or reliably reported by patient ≥ 3 times \ge 3\text{ times} ≥ 3 times within a 12-month period).

Plus at least TWO of the following:

Recurrent Genital Ulcerations: Painful, discrete aphthous ulcers occurring on the scrotum, penis, or vulva; characteristically heal with cicatricial scarring.

Characteristic Eye Lesions: Anterior uveitis, posterior uveitis, retinal vasculitis, or cellular vitritis confirmed by an ophthalmologist.

Characteristic Skin Lesions: Erythema nodosum-like lesions, pseudofolliculitis, papulopustular eruptions, or acneiform nodules in post-adolescent patients not receiving corticosteroids.

Positive Pathergy Test: Formation of a sterile erythematous papule or pustule ( ≥ 2 mm \ge 2\text{ mm} ≥ 2 mm in diameter) 24 to 48 hours following oblique intracutaneous puncture of the forearm with a sterile 20-gauge needle.

Ocular Manifestations

The 2014 ICBD system differs: ocular lesions, oral aphthosis and genital aphthosis each score two points; skin, neurological and vascular manifestations each score one, with one additional point for a positive pathergy test when performed. A score of at least four meets the classification threshold. Oral ulceration is therefore not compulsory in that system. For example, genital aphthosis plus characteristic ocular disease totals four points without oral aphthosis. Classification supports research and clinical assessment; exclude mimics and judge the entire presentation rather than diagnosing from an isolated score. See the original international criteria study .

Ocular involvement develops in 60% to 80% of Behçet patients, typically 2 to 4 years following the onset of oral aphthae, and exhibits a significantly more aggressive and vision-threatening course in young males:

Bilateral Non-Granulomatous Panuveitis: Explosive, recurrent attacks characterized by intense intraocular inflammation.

The "Cold" Hypopyon: A characteristic, sometimes mobile, cellular, highly fluid and mobile hypopyon that shifts rapidly with head repositioning. It is termed "cold" because it can arise in an eye with deceptively minimal conjunctival or ciliary injection, and typically resolves spontaneously within several days.

Occlusive Retinal Vasculitis: Affects both retinal veins and retinal arteries ( diffuse obliterative arteriolitis and phlebitis ):

Retinal branch vein and artery occlusions.

Diffuse retinal capillary non-perfusion, severe ischaemia, cotton-wool spots, and flame haemorrhages.

Optic disc and retinal neovascularisation leading to non-clearing vitreous haemorrhage and tractional retinal detachment.

Recurrent uncontrolled vascular inflammation can cause irreversible ischaemic macular and optic-nerve damage; early coordinated treatment and surveillance are essential.

Vogt-Koyanagi-Harada (VKH) Disease

VKH disease is a severe, bilateral, granulomatous autoimmune panuveitis targeting melanocyte-associated antigens (including tyrosinase, tyrosinase-related proteins TRP-1 and TRP-2, and MART-1/Melan-A). It characteristically affects darkly pigmented individuals (Asians, Hispanics, Native Americans, and Middle Easterners) and is strongly associated with HLA-DR4 and HLA-DRB1*0405 .

The Four Clinical Phases of VKH

Clinical Phase Chronological Timing Key Pathophysiological and Clinical Hallmarks

1. Prodromal Phase Days to 1–2 weeks Systemic viral-like illness: severe diffuse headache, deep orbital pain, meningismus, scalp hyperaesthesia, vertigo, tinnitus, and sensorineural hearing loss. Lumbar puncture reveals cerebrospinal fluid (CSF) lymphocytic pleocytosis in > 80 % >80\% > 80% of patients with normal glucose.

2. Acute Uveitic Phase Weeks Profound, acute, bilateral vision loss. Diffuse granulomatous choroiditis producing marked, thickened choroid on B-scan and EDI-OCT. Multifocal serous neurosensory retinal detachments (clover-leaf appearance at the posterior pole), optic disc hyperaemia and oedema, and moderate vitritis.

3. Convalescent Phase Weeks to months Depigmentation of ocular and integumentary melanocytes. Fundus develops a bright orange-red appearance: "sunset-glow fundus" due to loss of choroidal melanin. Dalén-Fuchs nodules (sub-RPE granulomas). Sugiura sign (perilimbal vitiligo, characteristic in Japanese cohorts). Cutaneous signs: poliosis (whitening of eyelashes, eyebrows, hair), vitiligo , and alopecia .

4. Chronic Recurrent Phase Months to years Characterized by smouldering, recurrent bouts of anterior uveitis with mutton-fat KPs, iris stroma atrophy, Koeppe/Busacca nodules, cataract, glaucoma, subretinal fibrosis, and macular choroidal neovascular membranes (CNVM). Recurrent posterior pole serous detachments are rare in this phase.

Assess activity and prevent complications

In Behçet disease, recurrent occlusive retinal vasculitis requires activity assessment and systemic coordination; acuity alone can miss active peripheral disease. In VKH, choroidal activity and recurrence may require imaging even after serous fluid improves. Monitor pressure, cataract, macular oedema and steroid toxicity in both disorders. Immunomodulatory selection and monitoring are taught with posterior inflammatory patterns, and should follow the phenotype rather than a fixed escalation ladder for all patients.